ZIOPHARM ONCOLOGY INC (45) | Human Resources (15)

Browse by Subcategory

Recent Contracts

Consulting Agreement by and between the Company and Dr. Laurence Cooper, entered into on April 5, 2021 (Filed With SEC on April 9, 2021)
Separation Agreement by and between the Company and Dr. Laurence Cooper, dated April 5, 2021 (Filed With SEC on April 9, 2021)
Employment Agreement by and between Ziopharm Oncology, Inc. and Heidi Hagen, dated February 25, 2021 (Filed With SEC on March 2, 2021)
Form of Stock Option Agreement Granted Under the ZIOPHARM Oncology, Inc. 2020 Equity Incentive Plan (Filed With SEC on March 1, 2021)
Form of Restricted Stock Agreement Granted Under the ZIOPHARM Oncology, Inc. 2020 Equity Incentive Plan (Filed With SEC on March 1, 2021)
Amendment to the Employment Agreement by and between the Registrant and Robert Hadfield, dated as of November 23, 2020 (Filed With SEC on March 1, 2021)
Amendment to the Employment Agreement by and between the Registrant and Sath Shukla, dated as of November 23, 2020 (Filed With SEC on March 1, 2021)
Form of Retention Bonus Agreement (Filed With SEC on March 1, 2021)
Consulting Agreement by and between Ziopharm Oncology Inc. and Danforth Advisors LLC, effective as of January 21, 2021 (Filed With SEC on February 23, 2021)
Ziopharm Oncology, Inc. 2020 Equity Incentive Plan (Filed With SEC on July 1, 2020)
Consulting Agreement by and between the Company and Dr. David Mauney, dated May 26, 2020 (Filed With SEC on May 29, 2020)
Separation Agreement and Release by and between the Company and Dr. David Mauney, effective May 26, 2020 (Filed With SEC on May 29, 2020)
Employment Agreement by and between Ziopharm Oncology, Inc. and Sath Shukla (Filed With SEC on July 24, 2019)
Employment Agreement, dated as of April 23, 2019, by and between the Company and David Mauney, M.D (Filed With SEC on April 29, 2019)
Employment Agreement, dated as of April 23, 2019, by and between the Company and Robert Hadfield (Filed With SEC on April 29, 2019)